Skip to main content

Table 8 Comparison of adult formulation derived costs to the WHO Global Price Reporting Mechanism (GPRM) database

From: Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations

Medication (strength)

Monthly costs for 35 + kg (from Table 3)

Monthly costs from GPRM

ABC (300 mg)

$15.81

$13.39

d4T (30 mg)

$1.82

$1.52

3TC (150 mg)

$2.43

$2.36

EFV (600 mg)

$4.56

$3.86

LPV/r (200/50 mg)

$31.62

$29.47

NVP (200 mg)

$3.04

$2.47

ZDV (300 mg)

$7.30

$6.98

ZDV/3TC (300 mg/150 mg)

$9.12

$7.86

ZDV/3TC/NVP (300 mg/150 mg/200 mg)

$11.55

$9.89

d4T/3TC (30 mg/150 mg)

$3.65

$2.99

d4T/3TC/NVP (30 mg/150 mg/200 mg)

$6.69

$4.76

ABC/3TC (600 mg/300 mg)

$17.72-$32.53

$22.56

  1. Abbreviations: ABC abacavir, d4T stavudine, 3TC lamivudine, EFV efavirenz, LPV/r lopinavir/ritonavir, NVP nevirapine, ZDV zidovudine, mg milligrams, ml milliliter, NR not recommended, N/A not applicable (no cost estimate was available from the GPRM for this formulation).